NO149034C - Analogifremgangsmaate til fremstilling av terapeutisk virksomme n-alkylerte aminoalkoholer - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk virksomme n-alkylerte aminoalkoholerInfo
- Publication number
- NO149034C NO149034C NO791841A NO791841A NO149034C NO 149034 C NO149034 C NO 149034C NO 791841 A NO791841 A NO 791841A NO 791841 A NO791841 A NO 791841A NO 149034 C NO149034 C NO 149034C
- Authority
- NO
- Norway
- Prior art keywords
- aminoal
- alkylated
- alcohols
- preparation
- therapeutically effective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH613678 | 1978-06-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO791841L NO791841L (no) | 1979-12-06 |
NO149034B NO149034B (no) | 1983-10-24 |
NO149034C true NO149034C (no) | 1984-02-01 |
Family
ID=4304840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO791841A NO149034C (no) | 1978-06-05 | 1979-06-01 | Analogifremgangsmaate til fremstilling av terapeutisk virksomme n-alkylerte aminoalkoholer |
Country Status (26)
Country | Link |
---|---|
US (1) | US4460580A (pl) |
EP (1) | EP0005848B1 (pl) |
JP (1) | JPS54163543A (pl) |
KR (4) | KR840000926B1 (pl) |
AR (3) | AR229581A1 (pl) |
AT (1) | ATE511T1 (pl) |
AU (1) | AU522483B2 (pl) |
CA (1) | CA1124241A (pl) |
CY (1) | CY1256A (pl) |
DD (1) | DD144050A5 (pl) |
DE (1) | DE2961669D1 (pl) |
DK (1) | DK229879A (pl) |
ES (1) | ES481238A1 (pl) |
FI (1) | FI791727A (pl) |
GB (1) | GB2026474B (pl) |
GR (1) | GR74057B (pl) |
HK (1) | HK15585A (pl) |
HU (1) | HU182019B (pl) |
IL (1) | IL57471A (pl) |
MY (1) | MY8500690A (pl) |
NO (1) | NO149034C (pl) |
NZ (1) | NZ190632A (pl) |
PL (5) | PL116597B1 (pl) |
PT (1) | PT69723A (pl) |
SG (1) | SG45884G (pl) |
ZA (1) | ZA792748B (pl) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0006735B1 (en) * | 1978-06-28 | 1983-06-15 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
CA1152517A (en) | 1979-06-29 | 1983-08-23 | Ian H. Coates | Heterocyclic compounds, processes for their preparation and their use |
DD202692A5 (de) * | 1979-12-04 | 1983-09-28 | Ciba Geigy | Verfahren zur herstellung neuer derivate des 2-amino-aethanols |
JPS5726653A (en) * | 1980-05-09 | 1982-02-12 | Ciba Geigy Ag | Substituted phenyl ether |
DE3026534A1 (de) * | 1980-07-12 | 1982-03-18 | C.H. Boehringer Sohn, 6507 Ingelheim | 3,1-benzoxazin-2-one, ihre herstellung und verwendung |
GR74992B (pl) * | 1980-08-13 | 1984-07-12 | Ciba Geigy Ag | |
JPS57185243A (en) * | 1981-05-08 | 1982-11-15 | Ciba Geigy Ag | Substituted 2-aminoethanol |
US4466965A (en) * | 1982-07-26 | 1984-08-21 | American Hospital Supply Corporation | Phthalazine compounds, compositions and use |
FR2543139B1 (fr) * | 1983-03-22 | 1985-08-16 | Cerm Cent Europ Rech Mauvernay | Derives de (1-alcoxy 2-amino) ethyl pyridine ou pyrazine, leur preparation et leur application en therapeutique |
DE3608290A1 (de) * | 1986-03-13 | 1987-09-24 | Thomae Gmbh Dr K | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE3621775A1 (de) * | 1986-03-13 | 1988-01-07 | Thomae Gmbh Dr K | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
CA1287061C (en) * | 1986-06-27 | 1991-07-30 | Roche Holding Ltd. | Pyridine ethanolamine derivatives |
GB8714901D0 (en) * | 1986-07-23 | 1987-07-29 | Ici Plc | Amide derivatives |
DE3627663A1 (de) * | 1986-08-14 | 1988-03-03 | Bayer Ag | Heteroarylethylamine, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer bei tieren |
US5108363A (en) * | 1988-02-19 | 1992-04-28 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
GB8925032D0 (en) * | 1989-11-06 | 1989-12-28 | Ici Plc | Chemical compounds |
JPH0466934A (ja) * | 1990-07-04 | 1992-03-03 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
US5232948A (en) * | 1990-09-10 | 1993-08-03 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
US6011068A (en) * | 1991-08-23 | 2000-01-04 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US5763569A (en) * | 1991-08-23 | 1998-06-09 | The Brigham And Women's Hospital, Inc | Calcium receptor-active molecules |
US6001884A (en) * | 1991-08-23 | 1999-12-14 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
ATE312347T1 (de) * | 1991-08-23 | 2005-12-15 | Nps Pharma Inc | Screening-verfahren für kalzium-rezeptor aktive verbindungen |
US5688938A (en) * | 1991-08-23 | 1997-11-18 | The Brigham & Women's Hospital, Inc. | Calcium receptor-active molecules |
US5858684A (en) * | 1991-08-23 | 1999-01-12 | The Brigham And Women's Hospital, Inc. | Method of screening calcium receptor-active molecules |
US6313146B1 (en) | 1991-08-23 | 2001-11-06 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US6031003A (en) * | 1991-08-23 | 2000-02-29 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
US5208252A (en) * | 1992-07-24 | 1993-05-04 | Ortho Pharmaceutical Corporation | Aminoethylthiophene derivatives |
US5962314A (en) * | 1993-02-23 | 1999-10-05 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
AU1533495A (en) * | 1994-01-12 | 1995-08-01 | Byk Nederland Bv | Phenyl ethanol amine ethers and uses thereof as beta-adreno-receptor agonists |
UA55374C2 (uk) | 1994-10-21 | 2003-04-15 | Нпс Фармасьютікалз, Інк | Сполуки, що мають активність по відношенню до рецепторів кальцію |
ES2280460T3 (es) | 1996-05-01 | 2007-09-16 | Nps Pharmaceuticals, Inc. | Compuestos activos frente a receptores de iones inorganicos. |
KR100380520B1 (ko) * | 2000-09-08 | 2003-04-23 | 한국화학연구원 | 피리딘을 포함한 β-아미노알코올 유도체 |
WO2003090251A1 (en) * | 2002-04-22 | 2003-10-30 | Koninklijke Philips Electronics N.V. | Luminescent screen |
US7538141B2 (en) * | 2004-03-23 | 2009-05-26 | Alan Daniel Brown | Compounds for the treatment of diseases |
WO2011112243A2 (en) * | 2010-03-08 | 2011-09-15 | The University Of Tennessee Research Foundation | Beta -adrenergic receptor agonists and uses thereof |
ITMI20122221A1 (it) * | 2012-12-21 | 2014-06-22 | C4T S C A R L | Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende |
CN104008939B (zh) * | 2014-06-19 | 2016-05-11 | 苏州普京真空技术有限公司 | 一种耐用电子枪灯丝 |
USD954933S1 (en) | 2018-06-01 | 2022-06-14 | Chiaro Technology Limited | Breast pump accessory |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1178400A (en) * | 1966-12-13 | 1970-01-21 | Delalande Sa | Nitrogen Substituted Amines and their process of Preparation. |
DE1543538A1 (de) * | 1966-12-30 | 1976-02-05 | Degussa | Verfahren zur herstellung neuer heterocyclischer aminoalkohole |
US4012444A (en) * | 1969-07-08 | 1977-03-15 | Allen & Hanburys Limited | 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof |
GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
GB1398738A (en) * | 1972-12-05 | 1975-06-25 | Pfizer Ltd | Propanolamine derivatives |
US4082772A (en) * | 1975-04-18 | 1978-04-04 | American Home Products Corporation | Thiophene ethanolamines |
US4146638A (en) * | 1976-02-17 | 1979-03-27 | Boehringer Ingelheim Gmbh | N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines |
-
1979
- 1979-05-30 DD DD79213267A patent/DD144050A5/de unknown
- 1979-05-30 FI FI791727A patent/FI791727A/fi not_active Application Discontinuation
- 1979-06-01 AT AT79101724T patent/ATE511T1/de active
- 1979-06-01 CY CY1256A patent/CY1256A/xx unknown
- 1979-06-01 CA CA328,929A patent/CA1124241A/en not_active Expired
- 1979-06-01 DE DE7979101724T patent/DE2961669D1/de not_active Expired
- 1979-06-01 EP EP79101724A patent/EP0005848B1/de not_active Expired
- 1979-06-01 DK DK229879A patent/DK229879A/da not_active Application Discontinuation
- 1979-06-01 NZ NZ190632A patent/NZ190632A/en unknown
- 1979-06-01 NO NO791841A patent/NO149034C/no unknown
- 1979-06-04 ES ES481238A patent/ES481238A1/es not_active Expired
- 1979-06-04 AU AU47736/79A patent/AU522483B2/en not_active Ceased
- 1979-06-04 PL PL1979222400A patent/PL116597B1/pl unknown
- 1979-06-04 PL PL1979216090A patent/PL116529B1/pl unknown
- 1979-06-04 PL PL1979222399A patent/PL116612B1/pl unknown
- 1979-06-04 GB GB7919470A patent/GB2026474B/en not_active Expired
- 1979-06-04 HU HU79CI1940A patent/HU182019B/hu unknown
- 1979-06-04 PL PL1979222398A patent/PL117158B1/pl unknown
- 1979-06-04 PT PT69723A patent/PT69723A/pt unknown
- 1979-06-04 IL IL57471A patent/IL57471A/xx unknown
- 1979-06-04 ZA ZA792748A patent/ZA792748B/xx unknown
- 1979-06-04 KR KR7901814A patent/KR840000926B1/ko active
- 1979-06-04 PL PL1979222397A patent/PL117155B1/pl unknown
- 1979-06-05 JP JP6952479A patent/JPS54163543A/ja active Pending
- 1979-06-05 GR GR59274A patent/GR74057B/el unknown
-
1980
- 1980-12-17 AR AR283670A patent/AR229581A1/es active
- 1980-12-17 AR AR283669A patent/AR229951A1/es active
- 1980-12-17 AR AR283668A patent/AR229022A1/es active
-
1982
- 1982-03-12 KR KR1019820001067A patent/KR830000680A/ko unknown
- 1982-03-12 KR KR1019820001066A patent/KR830000679A/ko unknown
- 1982-03-12 KR KR1019820001068A patent/KR830000681A/ko unknown
- 1982-06-24 US US06/391,814 patent/US4460580A/en not_active Expired - Fee Related
-
1984
- 1984-06-23 SG SG458/84A patent/SG45884G/en unknown
-
1985
- 1985-03-07 HK HK155/85A patent/HK15585A/xx unknown
- 1985-12-30 MY MY690/85A patent/MY8500690A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO149034C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme n-alkylerte aminoalkoholer | |
NO147950C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser | |
NO151622C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive carboxyalkyldipeptider | |
NO151588C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater | |
NO791831L (no) | Fremgangsmaate for fremstilling av aminotiazoler | |
NO154522C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater. | |
NO147953C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider | |
NO152255C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere | |
NO151088C (no) | Analogifremgangsmaate til fremstilling av farmakologisk virksomme silyl-glucosaminderivater | |
NO143796C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner | |
NO150155C (no) | Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser | |
NO145762C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser | |
NO150605C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinyl-aminoalkyletere | |
NO151239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner | |
NO149311C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive propanolindolderivater | |
NO146356C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater | |
NO151285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater | |
NO792651L (no) | Fremgangsmaate for fremstilling av spesielle steroider | |
NO151008C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser | |
NO151196C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater | |
NO146863C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer | |
NO146057C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater | |
NO791599L (no) | Fremgangsmaate for fremstilling av dibenzyletere | |
NO153258C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner | |
NO794090L (no) | Fremgangsmaate for fremstilling av klordioksyd |